What we do

Eliminate hearing loss
as a chronic condition

Rescue Hearing is a life science organization dedicated to developing an array of gene therapies towards eliminating hearing loss symptoms and providing hope for persons experiencing hearing loss and deafness.



Myrtelle Licenses Gene Therapy from Rescue Hearing Inc.

Rescue Hearing is thrilled to announce its entry into a Worldwide Exclusive License Agreement with the innovative company Myrtelle, promising to bring cutting-edge solutions to the world of hearing care!

May | 2022


Rescue Hearing

RHI is a team of internationally recognized physicians, surgeons, scientists, and drug development professionals who share a passion for developing gene therapies for persons with hearing loss.

Dr. Hinrich Staecker

Chief Scientific Officer

Dr. Xue Zhong Liu

Founding Scientific Advisor

Dr. Athanasia Warnecke

Scientific Advisor

Dr. Jeffrey Holt

Scientific Advisor

Our Products

Developing therapeutic solutions for hearing loss

RHI 100

Targets individuals born with progressive hearing loss.

RHI 200

Targets balance disorders. Proof of Concept (POC) studies complete.

RHI 300

Novel vector platform. POC studies underway.

Stay up to date with RHI

Connect with us on LinkedIn and follow our Facebook
for updates and exciting progress


Latest Blogs

Gene Therapy


TMPRSS3 Mutation | What it is and How it Relates to Genetic Hearing Loss

The transmembrane serine protease 3 (TMPRSS3) gene plays an important role for many of us. It gives important instructions…


Interview With Dr. Staecker: A Closer Look Into His Profession and Major Contributions Within RHI

Dr. Hinrich Staecker is a scientist and trailblazer in the research of life sciences, particularly in the field of hearing loss. His research…